Results for moxidectin translation from English to Maltese

moxidectin
moksidektin

imidacloprid / moxidectin
imidakloprid / moksidektin

& 2.5% moxidectin
imidakloprid u 2.5

moxidectin [mg/kg bw]
moksidektin [mg/kg piż tal- ġisem]

following absorption from the skin, moxidectin is distributed
wara li jgħaddi għal ġol- ġilda, moksidektin jinfirex b´mod sistematiku u jiġi mneħħi bil- mod mill- plasma.

it contains two active substances, imidacloprid and moxidectin.
fih żewġ sustanzi attivi, l-imidakloprid u l-moksidektin.

moxidectin interacts with gaba and glutamate- gated chloride channels.
moksidektin għandu effett fuq aċidu gammaaminobutiriku u glutamate-gated chloride channels.

active substances: 40 mg imidacloprid, 4 mg moxidectin benzyl alcohol
sustanzi attivi: 40 mg imidakloprid, 4mg moksidektin benzyl alchol

simparica was as effective as moxidectin and imidacloprid in eliminating live mites in skin scrapings.
simparica kien effikaċi daqs moxidectin u imidacloprid biex jelimina d-dud ħaj mill-kampjuni tal-ġilda.

advocate 100 mg + 25 mg spot-on solution for medium dogs imidacloprid, moxidectin
advocate 100 mg + 25 mg taħlita likwida għal użu lokalizzat fuq klieb ta’ daqs medju imidakloprid, moksidektin

moxidectin is active against larval stages (l3, l4) of dirofilaria immitis.
moksidektin taħdem kontra stadji tal-larva (l3, l4) tad-dirofilaria immitis.

advocate 250 mg + 62.5 mg spot-on solution for large dogs imidacloprid, moxidectin
advocate 250 mg + 62.5 mg taħlita likwida għal użu lokalizzat fuq klieb kbar imidakloprid, moksidektin

53 dogs were treated with simparica for two months whilst 26 dogs were given a medicine containing moxidectin and imidacloprid.
53 kelb kienu kkurati b'simparica għal xahrejn filwaqt li 26 kienu kkurati b'mediċina li fiha moxidectin u imidacloprid.

advocate is a clear yellow to brownish antiparasitic solution that contains two active substances, imidacloprid and moxidectin.
advocate huwa soluzzjoni trasparenti ta 'kulur isfar fil- kannella għal kontra l- parassiti li fih żewġ sustanzi attivi, imidacloprid u moxidectin.

laboratory studies with either imidacloprid or moxidectin in rats and rabbits have not produced any evidence of teratogenic, foetotoxic or maternotoxic effects.
studji fil-laboratorju bl-użu t’imidakloprid u moksidektin fuq il-far u l-fniek ma pprovdewx evidenza ta' periklu fit-tqala, ħsara lill-fetu jew ħsara lill-omm.

80 mg imidacloprid, 8 mg moxidectin benzyl alcohol 1 mg/ ml butylhydroxytoluene (e321: as antioxidant)
80 mg imidakloprid, 8 mg moksidektin benzyl alcohol 1 mg/ ml butylhydroxytoluene (e321: bħala antiossidant)

dogs were treated with promeris duo or the combination of imidacloprid and moxidectin (another medicine authorised in the eu for this indication).
il-klieb ingħataw promeris duo jew kombinazzjoni ta’ imidacloprid u moxidectin (mediċina oħra awtorizzata fl-ue għal din l-indikazzjoni).

moxidectin is active against larval stages of dirofilaria immitis (l3, l4) and dirofilaria repens (l3).
moxidectin hu attiv kontra l-istadji tal-larva ta’ dirofilaria immitis (l3, l4) u dirofilaria repens (l3).

moxidectin, 23-(o-methyloxime)-f28249 alpha is a second-generation macrocyclic lactone of the milbemycin family.
14 m´għandux effett fuq is- sistema ċentrali ta´l- annimali li jreddgħu.

the recommended minimum doses are 10 mg/ kg bodyweight imidacloprid and 1.0 mg/ kg bodyweight moxidectin, equivalent to 0.1 ml/ kg bodyweight advocate for cats.
id- dożi minimi rrikkmandati huma ta´10mg imidakloprid għal kull kg użin tal- ġisem. u 1. 0 mg moksidektin għal kull kg użin tal- ġisem, li jiġu ekwivalenti għal 0. 1ml advocate għall- qtates, għal kull kg użin tal- ġisem.